Clinical Case of Tofacitinib Therapy in Autoimmune Alopecia in Patient with Ulcerative Colitis

    September 2022 in “ BioNanoScience ”
    E. S. BODRYAGINA, А. Х. Одинцова, Natalia Cheremina … Д. И. Абдулганиева
    Studysummary This clinical case report describes a patient with ulcerative colitis whose symptoms improved using the Janus kinase inhibitor, tofacitinib, allowing disease remission and hair regrowth.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Gut Instinct: Using Tofacitinib to Treat Alopecia Areata in the Context of Comorbid Inflammatory Bowel Disease JAAD Case Reports · 2020
    2. JAK Inhibitors: New Players in the Field of Immune-Mediated Diseases Beyond Rheumatoid Arthritis Rheumatology · 2018
    3. Alopecia Universalis Associated with Ulcerative Colitis and the Role of Azathioprine Middle East Journal of Digestive Diseases · 2018
    4. Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement After Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies Dermatology and therapy · 2016

    Related research 1

    1. Clinical Case of Tofacitinib Therapy in Autoimmune Alopecia in Patient with Ulcerative Colitis BioNanoScience · 2022